COGT

5.13

6.65% 0.32

Dopo l'orario di chiusura: 5.05 -0.08 -1.56%

Cogent Biosciences Inc (COGT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$4.81

Aprire:

$5.07

Volume 24 ore:

796.31K

Relative Volume:

0.60

Capitalizzazione di mercato:

$634.18M

Reddito:

Utile/perdita netta:

$-242.30M

Rapporto P/E:

-2.0685

EPS:

-2.48

Flusso di cassa netto:

$-192.10M

1 W Prestazione:

-7.90%

1M Prestazione:

+20.42%

6M Prestazione:

-50.58%

1 anno Prestazione:

-32.14%

Intervallo 1D:

$5.07

$5.30

Intervallo di 1 settimana:

$4.5505

$5.74

Portata 52W:

$3.72

$12.61

Cogent Biosciences Inc Stock (COGT) Company Profile

Nome

Cogent Biosciences Inc

Settore

Healthcare (1181)

Industria

Biotechnology (676)

Telefono

617-945-5576

Indirizzo

275 WYMAN STREET, WALTHAM

Dipendente

205

Cinguettio

Prossima data di guadagno

2024-10-31

Ultimi documenti SEC

COGT's Discussions on Twitter

Confronta COGT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
COGT Cogent Biosciences Inc	5.13	634.18M	0	-242.30M	-192.10M	-2.48
VRTX Vertex Pharmaceuticals Inc	439.37	128.45B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	575.63	65.17B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	560.90	40.09B	2.58B	1.06B	-1.28B	16.33
ALNY Alnylam Pharmaceuticals Inc	270.19	35.67B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	233.25	27.44B	3.81B	-644.79M	-669.77M	-6.24

Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-07	Iniziato	Scotiabank	Sector Outperform
2024-12-11	Downgrade	Needham	Buy → Hold
2024-02-26	Downgrade	Robert W. Baird	Outperform → Neutral
2024-02-08	Iniziato	Citigroup	Buy
2023-12-11	Downgrade	Wedbush	Outperform → Neutral
2023-12-08	Iniziato	JP Morgan	Overweight
2023-04-28	Iniziato	Robert W. Baird	Outperform
2023-03-27	Ripresa	H.C. Wainwright	Buy
2022-12-14	Iniziato	Needham	Buy
2022-06-28	Iniziato	Guggenheim	Buy
2021-10-11	Iniziato	H.C. Wainwright	Buy
2021-06-09	Ripresa	Jefferies	Buy
2020-12-23	Iniziato	Piper Sandler	Overweight
2020-10-14	Iniziato	Ladenburg Thalmann	Buy

Mostra tutto

Cogent Biosciences Inc Borsa (COGT) Ultime notizie

08:05 AM

10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey

08:05 AM

04:38 AM

Q2 EPS Estimate for Cogent Biosciences Lifted by Analyst - Defense World

04:38 AM

03:51 AM

Dimensional Fund Advisors LP Lowers Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

03:51 AM

May 11, 2025

Research Analysts Offer Predictions for COGT FY2028 Earnings - Defense World

May 11, 2025

May 10, 2025

Robert W. Baird Cuts Cogent Biosciences (NASDAQ:COGT) Price Target to $7.00 - Defense World

May 10, 2025

May 08, 2025

Cogent Biosciences (NASDAQ:COGT) Releases Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

May 08, 2025

May 07, 2025

Stock Surge: Cogent Biosciences Inc (COGT) Closes at 4.70, Marking a -15.62 Increase/Decrease - DWinneX

May 07, 2025

Cogent Biosciences (COGT) Maintains Neutral Rating Amid PT Adjustment | COGT Stock News - GuruFocus

May 07, 2025

Cogent Biosciences (COGT) Price Target Reduced by Baird | COGT Stock News - GuruFocus

May 07, 2025

Cogent Biosciences Advances with Promising Clinical Trials - TipRanks

May 07, 2025

MetLife Investment Management LLC Has $443,000 Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

May 07, 2025

Invesco Ltd. Sells 455,437 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

May 07, 2025

May 06, 2025

Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - Barchart.com

May 06, 2025

Wedbush Trims Price Target on Cogent Biosciences to $10 From $11, Maintains Neutral Rating - marketscreener.com

May 06, 2025

Cogent Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 06, 2025